Want to see ARTV full AI Analyst Report?
Artiva Biotherapeutics, Inc. (ARTV) Income Statement
Artiva Biotherapeutics, Inc. Income Statement
Last quarter (Q2 2026), Artiva Biotherapeutics, Inc.'s total revenue was $0.00. In Q2, Artiva Biotherapeutics, Inc.'s net income was $-25.00M. See Artiva Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 251.00K | $ 33.49M | $ 4.93M | $ 2.00M | |
| $ -2.60M | $ 251.00K | $ 33.49M | $ 4.93M | $ 2.00M | |
| $ 88.01M | $ 67.53M | $ 64.16M | $ 64.76M | $ 55.27M | |
| Depreciation and Amortization | $ 2.60M | $ 2.43M | $ 2.27M | $ 1.16M | $ 248.00K |
| $ -81.27M | $ -56.06M | $ -25.36M | $ -57.18M | $ -71.58M | |
| $ -90.61M | $ -67.28M | $ -30.67M | $ -59.83M | $ -53.27M | |
| $ 6.75M | $ 8.79M | $ 3.05M | $ 1.49M | $ -18.55M | |
| $ -83.86M | $ -58.49M | $ -27.62M | $ -58.34M | $ -71.83M | |
| $ -83.86M | $ -58.49M | $ -27.70M | $ -58.39M | $ -71.83M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.43 | $ -5.20 | $ -1.19 | $ -3.32 | $ -4.08 |
| Diluted EPS | $ -3.43 | $ -5.20 | $ -1.19 | $ -3.32 | $ -4.08 |
| Weighted Average Shares Outstanding | 24.44M | 24.36M | 23.28M | 17.58M | 17.58M |
| Weighted Average Shares Outstanding (Diluted) | 24.44M | 24.36M | 23.28M | 17.58M | 17.58M |
Currency in USD
